{
  "questionId": "MISSION-500-73-1771347556762",
  "itemType": "matrixMatch",
  "caseId": null,
  "question": "The nurse is caring for a 72-year-old male client admitted at 1600 for Hyperosmolar Hyperglycemic State (HHS). The nurse reviews the client's electronic health record (EHR). For each potential nursing action, specify if the action is indicated, not indicated, or contraindicated based on the client's current status.",
  "tabs": [
    {
      "tabId": "tab1",
      "tabTitle": "Nurses' Notes",
      "tabContent": [
        {
          "type": "note",
          "time": "1200 (ED)",
          "author": "ED RN",
          "content": "72-year-old male from a rural home found confused and lethargic by a neighbor. History of HTN, HFpEF, and poorly controlled Type 2 DM. Skin tenting present, mucous membranes are dry. Oriented to person only. Extremely thirsty. Initiated 0.9% NaCl bolus and regular insulin infusion per protocol."
        },
        {
          "type": "note",
          "time": "Current",
          "author": "ICU RN",
          "content": "Patient has become increasingly restless over the last hour. Arousable to loud voice, but falls back asleep quickly. New fine crackles auscultated bilaterally in lower lung bases. A productive cough with scant pink, frothy sputum was just noted. 3+ pitting edema present in bilateral lower extremities. Urine output has decreased to < 20 mL/hr."
        }
      ]
    },
    {
      "tabId": "tab2",
      "tabTitle": "Vital Signs",
      "tabContent": [
        {
          "type": "table",
          "title": "Trended Vital Signs",
          "columns": [
            "Time",
            "HR (bpm)",
            "BP (mmHg)",
            "RR (breaths/min)",
            "SpO2"
          ],
          "rows": [
            [
              "1200 (ED)",
              "125",
              "88/50",
              "24",
              "94% on RA"
            ],
            [
              "1400 (ICU)",
              "105",
              "105/65",
              "20",
              "96% on 2L NC"
            ],
            [
              "Current",
              "130",
              "90/60",
              "28",
              "88% on 2L NC"
            ]
          ]
        }
      ]
    },
    {
      "tabId": "tab3",
      "tabTitle": "Lab Results",
      "tabContent": [
        {
          "type": "table",
          "title": "Chemistry Panel",
          "columns": [
            "Lab",
            "1200 (ED)",
            "Current",
            "Reference Range"
          ],
          "rows": [
            [
              "Glucose (mg/dL)",
              "950",
              "450",
              "70-110"
            ],
            [
              "Sodium (mEq/L)",
              "155",
              "142",
              "136-145"
            ],
            [
              "Potassium (mEq/L)",
              "5.8",
              "2.9",
              "3.5-5.0"
            ],
            [
              "BUN (mg/dL)",
              "90",
              "75",
              "10-20"
            ],
            [
              "Creatinine (mg/dL)",
              "2.8",
              "2.5",
              "0.6-1.2"
            ],
            [
              "Serum Osmolality (mOsm/kg)",
              "360",
              "330",
              "275-295"
            ]
          ]
        },
        {
          "type": "table",
          "title": "Cardiac & Other Labs",
          "columns": [
            "Lab",
            "Current",
            "Reference Range"
          ],
          "rows": [
            [
              "Troponin I (ng/mL)",
              "0.50",
              "< 0.04"
            ],
            [
              "Lactate (mmol/L)",
              "4.2",
              "0.5-2.2"
            ]
          ]
        }
      ]
    },
    {
      "tabId": "tab4",
      "tabTitle": "MAR",
      "tabContent": [
        {
          "type": "mar",
          "medications": [
            {
              "name": "0.9% NaCl Infusion",
              "dose": "250 mL/hr",
              "route": "IV",
              "status": "Active"
            },
            {
              "name": "Regular Insulin Infusion",
              "dose": "5 units/hr",
              "route": "IV",
              "status": "Active"
            },
            {
              "name": "Potassium Chloride",
              "dose": "10 mEq in 100mL NS",
              "route": "IVPB",
              "status": "Ordered"
            }
          ]
        }
      ]
    }
  ],
  "matrixRows": [
    {
      "rowId": "row1",
      "rowText": "Continue 0.9% NaCl infusion at 250 mL/hr."
    },
    {
      "rowId": "row2",
      "rowText": "Administer the ordered Potassium Chloride 10 mEq IVPB."
    },
    {
      "rowId": "row3",
      "rowText": "Increase oxygen delivery via a non-rebreather mask."
    },
    {
      "rowId": "row4",
      "rowText": "Prepare for administration of a loop diuretic (e.g., furosemide)."
    },
    {
      "rowId": "row5",
      "rowText": "Decrease the regular insulin infusion rate."
    },
    {
      "rowId": "row6",
      "rowText": "Place the client in a supine position."
    }
  ],
  "matrixColumns": [
    {
      "columnId": "col1",
      "columnText": "Indicated"
    },
    {
      "columnId": "col2",
      "columnText": "Not Indicated"
    },
    {
      "columnId": "col3",
      "columnText": "Contraindicated"
    }
  ],
  "correctResponse": [
    {
      "rowId": "row1",
      "columnId": "col3"
    },
    {
      "rowId": "row2",
      "columnId": "col1"
    },
    {
      "rowId": "row3",
      "columnId": "col1"
    },
    {
      "rowId": "row4",
      "columnId": "col1"
    },
    {
      "rowId": "row5",
      "columnId": "col2"
    },
    {
      "rowId": "row6",
      "columnId": "col3"
    }
  ],
  "answerBreakdown": {
    "row1": {
      "columnId": "col3",
      "rationale": "Contraindicated. The client exhibits signs of fluid volume overload and pulmonary edema (crackles, pink frothy sputum, tachypnea, tachycardia, hypoxia, edema), likely due to aggressive fluid resuscitation given the underlying heart failure (HFpEF). Continuing IV fluids at this rate will worsen cardiogenic shock, evidenced by hypotension, elevated troponin, and high lactate. In HHS, hyperglycemia leads to osmotic diuresis and dehydration. Initial treatment involves fluid replacement, typically with 0.9% NaCl. However, in clients with HFpEF, the heart's ability to effectively pump blood is compromised. Excessive fluid administration increases preload, leading to pulmonary congestion and reduced cardiac output. The elevated troponin and lactate suggest myocardial ischemia due to increased cardiac workload and decreased oxygen delivery.",
      "clinicalPearl": "Aggressive fluid resuscitation in HHS can lead to fluid overload, especially in clients with underlying cardiac conditions. Monitor for signs of pulmonary edema and adjust fluid administration accordingly. Assess cardiac function before and during fluid resuscitation."
    },
    "row2": {
      "columnId": "col1",
      "rationale": "Indicated. The client's potassium level is critically low at 2.9 mEq/L. Insulin therapy shifts potassium intracellularly, and rehydration dilutes it, causing a rapid drop from the initially high admission level. Severe hypokalemia can cause life-threatening cardiac dysrhythmias. In HHS, hyperglycemia causes osmotic diuresis, leading to potassium loss through the kidneys. Insulin administration further exacerbates hypokalemia by promoting potassium uptake into cells. This intracellular shift reduces serum potassium levels, potentially causing cardiac instability. The ordered potassium chloride will help restore the potassium balance and prevent cardiac complications.",
      "clinicalPearl": "Monitor potassium levels closely during insulin therapy for HHS, as rapid correction of hyperglycemia can lead to hypokalemia. Cardiac monitoring is essential during potassium replacement. Administer potassium cautiously and monitor for signs of hyperkalemia."
    },
    "row3": {
      "columnId": "col1",
      "rationale": "Indicated. The client is acutely hypoxic (SpO2 88%) and in respiratory distress (RR 28). The immediate priority is to correct hypoxemia to prevent further end-organ damage. A non-rebreather mask provides the highest concentration of oxygen via a low-flow system and is an appropriate intervention. Hypoxemia in HHS can result from several factors, including fluid overload leading to pulmonary edema, impaired gas exchange due to alveolar fluid accumulation, and increased oxygen demand due to metabolic stress. The non-rebreather mask delivers a high concentration of oxygen, increasing the partial pressure of oxygen in the alveoli and improving oxygen saturation.",
      "clinicalPearl": "Hypoxemia in HHS can be multifactorial, including fluid overload and impaired gas exchange. Prompt oxygen administration is crucial to prevent complications. Monitor oxygen saturation and respiratory effort closely."
    },
    "row4": {
      "columnId": "col1",
      "rationale": "Indicated. Given the clear evidence of fluid overload (pulmonary edema), the nurse should anticipate a provider's order for a loop diuretic like furosemide to rapidly excrete excess fluid, decrease preload, and improve respiratory status. Proactively preparing the medication is an appropriate nursing action. Loop diuretics, such as furosemide, inhibit sodium and chloride reabsorption in the loop of Henle, promoting water excretion. In the context of HHS complicated by heart failure, loop diuretics reduce circulating blood volume, decreasing preload and alleviating pulmonary congestion. This improves cardiac output and reduces the workload on the heart.",
      "clinicalPearl": "Loop diuretics are often necessary to manage fluid overload in HHS, especially when complicated by heart failure. Monitor electrolytes closely during diuretic therapy. Assess for signs of dehydration and electrolyte imbalances, such as hypokalemia and hyponatremia."
    },
    "row5": {
      "columnId": "col2",
      "rationale": "Not indicated. While the glucose has improved, it remains dangerously high at 450 mg/dL. The insulin infusion is essential for correcting hyperglycemia and hyperosmolality. The rate of glucose reduction should be controlled (target 50-70 mg/dL/hr), but decreasing the infusion is not the priority action given the overall clinical picture and could hinder metabolic recovery. In HHS, insulin facilitates glucose uptake into cells, reducing serum glucose levels. The goal is to gradually lower glucose levels to prevent complications such as cerebral edema. Abruptly decreasing the insulin infusion rate could lead to rebound hyperglycemia and exacerbate the hyperosmolar state.",
      "clinicalPearl": "The goal of insulin therapy in HHS is to gradually reduce glucose levels while avoiding rapid shifts that can lead to cerebral edema. Frequent glucose monitoring is essential to guide insulin adjustments. Monitor for signs of hypoglycemia and adjust insulin infusion accordingly."
    },
    "row6": {
      "columnId": "col3",
      "rationale": "Contraindicated. Placing a client with pulmonary edema and respiratory distress in a supine position worsens ventilation by increasing pressure on the diaphragm and promoting fluid accumulation in the lungs. This would severely increase the work of breathing. The client should be positioned upright, such as in a high-Fowler's position, to facilitate lung expansion and ease breathing. In a supine position, abdominal contents push against the diaphragm, limiting lung expansion. This is particularly problematic in clients with pulmonary edema, where fluid accumulation in the alveoli impairs gas exchange. An upright position, such as high-Fowler's, reduces pressure on the diaphragm, allowing for greater lung expansion and improved ventilation.",
      "clinicalPearl": "Positioning is crucial for clients with respiratory distress. Elevating the head of the bed promotes lung expansion and reduces the work of breathing. Assess respiratory effort and adjust positioning as needed."
    }
  },
  "sbar": {
    "situation": "72-year-old male admitted at 1600 for Hyperosmolar Hyperglycemic State (HHS) with new onset pulmonary edema.",
    "background": "History of HTN, HFpEF, and poorly controlled Type 2 DM. Admitted with confusion, lethargy, and dehydration. Initial glucose 950 mg/dL, now 450 mg/dL. Receiving 0.9% NaCl at 250 mL/hr and regular insulin at 5 units/hr.",
    "assessment": "Increasing restlessness, decreased level of consciousness, new crackles in lower lung bases, productive cough with pink, frothy sputum, 3+ pitting edema, decreased urine output (< 20 mL/hr), SpO2 88% on 2L NC, HR 130 bpm, BP 90/60 mmHg, RR 28 breaths/min, potassium 2.9 mEq/L, troponin 0.50 ng/mL, lactate 4.2 mmol/L.",
    "recommendation": "Discontinue 0.9% NaCl infusion. Administer ordered potassium chloride. Increase oxygen delivery via non-rebreather mask. Prepare for administration of a loop diuretic (e.g., furosemide). Continue regular insulin infusion, monitoring glucose closely. Elevate head of bed to high-Fowler's position. Monitor vital signs, respiratory status, and urine output closely."
  },
  "sentinelStatus": "healed_v2026_v8"
}